UBS AM’s Kyverna Therapeutics KYTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-101,900	Closed	-$498K	–	2770
2024 Q3	$498K	Sell	101,900 -13,465	-12%	-$65.8K	﹤0.01%	2647
2024 Q2	$865K	Buy	115,365 +9,465	+9%	+$71K	﹤0.01%	2449
2024 Q1	$2.63M	Buy	+105,900	New	+$2.63M	﹤0.01%	1541